Category: Hot Opportunities

Rekor Systems Inc. (REKR) stock prices were down by 5.74% as of the market closing on October 1st, 2021. This brought the price per share down to USD$10.83 at the end of the trading day. REKR Stock Partners with Toyota September 30th, 2021 saw REKR stock announce the collaboration of its Waycare Technologies subsidiary with Toyota Mobility Foundation. The partnership will serve to reduce traffic congestion and incidents in Bangkok, Thailand. The deployment is expected to continue for a year, targeting the country’s oldest and busiest road: Rama IV Road in Bangkok. Traffic incidents account for the loss of lives

PEDEVCO Corp. (PED) saw a decrease of 10.43% in the aftermarket. However, the last trading session concluded at $2.11 with an incline of 42.57%. Second Quarter 2021 Financial Results PED announced second-quarter 2021 financial results on 17th August 2021. Firstly, oil and gas output grew by 40% to 718 barrels of oil equivalent per day. The rise in output was largely due to production from the Company’s operated wells, which were shut-in for 42 days during the second quarter of 2020. This owed to a severe fall in price, as well as considerably wider differentials from lower demand due to

Beyond Air, Inc. (XAIR) has experienced an incline of 11.88% in the aftermarket. However, the last trading session closed at $10.61 with a decrease of 4.59%. Global Regulatory Update for LungFit On 21st September 2021, XAIR gave an update on the LungFit PH system’s global regulatory clearance process. XAIR has passed the Stage 1 Assessment Audit of its quality system undertaken by the Notified Body for the LungFit PH system. It is required for CE Mark certification (European Union approval). This is the first stage of a two-part inspection and quality assurance audit. In Europe, LungFit® PH is scheduled to

Vyant Bio, Inc. (VYNT) stock rose to 5.53% in the aftermarket. However, the last trading session closed at $2.35 with an incline of 0.86%. Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder On 9th September 2021, VYNT announced that it has established non-exclusive strategic cooperation with Cyclica. This agreement is to seek novel therapies for CDKL5 Deficiency Condition which is a severe neurodevelopmental epilepsy disorder with no viable treatments or cure. Vyant Bio’s human-first strategy to novel pharmaceutical research uses highly functional, genetic disorder neural organoids in the early stages of the process. While Cyclica’s proprietary machine learning

Shares of the Biomerica, Inc. (BMRA) stock were soaring today following the announcement of its agreement with Walmart. BMRA stock price saw a surge of 34.22% to reach $6.00 a share at the time of this writing. The stock was gloomy in the previous trade and went down by 3.43% at closing. Let’s discuss BMRA stock in-depth and understand its recent events. Biomerica, Inc is the medical stock that operates by developing, manufacturing, and marketing of therapeutics to treat medical conditions across the globe. The company is manufacturing diagnostics kits that analyze blood, urine, and fecal specimens to diagnose medical

Zomedica Corp. (ZOM) stock prices were up by 3.15% as of the market closing on September 30th 2021. This brought the price per share up to USD$.0.52 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 20.36%, bringing it up to USD$0.63. ZOM Stock’s Partnership October 1st 2021 saw ZOM stock announce the acquisition of Pulse Veterinary Technologies. As per the agreement, the transaction amounted to USD$70.9 million and consisted of a mix of cash and stock options. Pulse Veterinary Tech is a world leader in electro-hydraulic shock wave technology. This technology has

Shares of the Bit Digital, Inc. (BTBT) stock were rising in the premarket session after it announced an $80 million private placement. BTBT stock price saw a push of 6.09% to reach $7.67 a share at the time of this writing. The stock was gloomy in the previous trade and went low by 8.60% at closing. Bit Digital is the bitcoin mining company that was previously known as Golden Bull Limited. The company was founded in 2017 and its headquarter are located in New York, New York. What’s Happening? Bit Digital stock today announced that it has signed a definitive

Shares of the SunPower Corporation (SPWR) stock climbed in the After Market trading session on September 30, 2021. The previously increasing per-share price of SPWR stock got more hype after SunPower announced the launch of SunPower 25X25. SPWR stock price saw a push of 10.05% to reach $2.28 a share in the aftermarket session bringing per share price $24.96. Let’s take a deep look at this stock. SunPower Corporation runs its business by delivering solar solutions across the globe. It is operating through various segments including Light Commercial, Residential, and Commercial and Industrial Solutions. The company was founded in 1985

Molecular Data Inc. (MKD) has seen an increase of 12.06% in the aftermarket. However, the last trading session concluded at $0.3516 with a decrease of 2.33%. MKD Closes $15 Million Registered Direct Offering On 22 September 2021, MKD announced the completion of its previously announced registered direct offering. It consisted of one American Depositary Share or ADS. Each one of them represents three of its Class A ordinary shares, and one warrant to purchase one ADS. pre-funded units, which consist of one pre-funded warrant to purchase one ADS and one warrant to purchase one ADS. Prior to deducting placement agent

Alzamend Neuro Inc. (ALZN) stock prices surged by 39.04% some time after market trading commenced on September 30th, 2021. This brought the price per share up to USD$3.17 early on in the trading day. FDA Approval of Pre-Investigational IND September 30th, 2021 saw ALZN stock announce having received a written response to its meeting request. The meeting request was in relation to the company’s Type B Pre-Investigational New Drug application from the U.S Food and Drug Administration. This is hoped to facilitate a path for the company’s clinical development of AL002 as planned. The treatment is a patented method that